We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Investigation of the Effect of PD-L1 Blockade on Triple Negative Breast Cancer Cells Using Fourier Transform Infrared Spectroscopy.
- Authors
Ali, Mohamed H. M.; Toor, Salman M; Rakib, Fazle; Mall, Raghvendra; Ullah, Ehsan; Mroue, Kamal; Kolatkar, Prasanna R.; Al-Saad, Khalid; Elkord, Eyad
- Abstract
Interactions between programmed death-1 (PD-1) with its ligand PD-L1 on tumor cells can antagonize T cell responses. Inhibiting these interactions using immune checkpoint inhibitors has shown promise in cancer immunotherapy. MDA-MB-231 is a triple negative breast cancer cell line that expresses PD-L1. In this study, we investigated the biochemical changes in MDA-MB-231 cells following treatment with atezolizumab, a specific PD-L1 blocker. Our readouts were Fourier Transform Infrared (FTIR) spectroscopy and flow cytometric analyses. Chemometrical analysis, such as principal component analysis (PCA), was applied to delineate the spectral differences. We were able to identify the chemical alterations in both protein and lipid structure of the treated cells. We found that there was a shift from random coil and α-helical structure to β-sheet conformation of PD-L1 on tumor cells due to atezolizumab treatment, which could hinder binding with its receptors on immune cells, ensuring sustained T cell activation for potent immune responses. This work provides novel information about the effects of atezolizumab at molecular and cellular levels. FTIR bio-spectroscopy, in combination with chemometric analyses, may expedite research and offer new approaches for cancer immunology.
- Subjects
FOURIER transform infrared spectroscopy; CANCER cells; CELL anatomy; MULTIPLE correspondence analysis (Statistics); CELL receptors; TRIPLE-negative breast cancer
- Publication
Vaccines, 2019, Vol 7, Issue 3, p109
- ISSN
2076-393X
- Publication type
Article
- DOI
10.3390/vaccines7030109